Suppr超能文献

突变阳性家族性高胆固醇血症中各类心血管疾病的风险;综述

The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review.

作者信息

Hovland Anders, Mundal Liv J, Veierød Marit B, Holven Kirsten B, Bogsrud Martin Prøven, Tell Grethe S, Leren Trond P, Retterstøl Kjetil

机构信息

Nordland Heart Center, Bodø, Norway.

The Lipid Clinic, Oslo University Hospital, Oslo, Norway.

出版信息

Front Genet. 2022 Dec 6;13:1072108. doi: 10.3389/fgene.2022.1072108. eCollection 2022.

Abstract

Familial hypercholesterolemia (FH) is a common, inherited disease characterized by high levels of low-density lipoprotein Cholesterol (LDL-C) from birth. Any diseases associated with increased LDL-C levels including atherosclerotic cardiovascular diseases (ASCVDs) would be expected to be overrepresented among FH patients. There are several clinical scoring systems aiming to diagnose FH, however; most individuals who meet the clinical criteria for a FH diagnosis do not have a mutation causing FH. In this review, we aim to summarize the literature on the risk for the various forms of ASCVD in subjects with a proven FH-mutation (FH+). We searched for studies on FH+ and cardiovascular diseases and also included our and other groups published papers on FH + on a wide range of cardiovascular and other diseases of the heart and vessels. FH + patients are at a markedly increased risk of a broad range of ASCVD. Acute myocardial infarction (AMI) is the most common in absolute numbers, but also aortic valve stenosis is by far associated with the highest excess risk. Per thousand patients, we observed 3.6 incident AMI per year compared to 1.9 incident aortic valve stenosis, however, standardized incidence ratio (SIR) for incident AMI was 2.3 compared to 7.9 for incident aortic valve stenosis. Further, occurrence of ischemic stroke seems not to be associated with increased risk in FH+. Clinicians should be aware of the excess risk of almost all kind of ASCVD in FH+, and the neutral risk of stroke need to be studied further in FH + patients.

摘要

家族性高胆固醇血症(FH)是一种常见的遗传性疾病,其特征是从出生起低密度脂蛋白胆固醇(LDL-C)水平就很高。任何与LDL-C水平升高相关的疾病,包括动脉粥样硬化性心血管疾病(ASCVD),在FH患者中的比例预计都会过高。然而,有几种临床评分系统旨在诊断FH;大多数符合FH诊断临床标准的个体并没有导致FH的突变。在本综述中,我们旨在总结关于已证实有FH突变(FH+)的受试者发生各种形式ASCVD风险的文献。我们检索了关于FH+与心血管疾病的研究,并纳入了我们和其他团队发表的关于FH+与广泛的心血管及其他心脏和血管疾病的论文。FH+患者发生多种ASCVD的风险显著增加。急性心肌梗死(AMI)在绝对数量上是最常见的,但主动脉瓣狭窄目前也是与最高额外风险相关的疾病。每千名患者中,我们观察到每年有3.6例AMI发病,而主动脉瓣狭窄发病为1.9例,然而,AMI的标准化发病率(SIR)为2.3,而主动脉瓣狭窄的SIR为7.9。此外,缺血性卒中的发生似乎与FH+患者的风险增加无关。临床医生应意识到FH+患者几乎所有类型ASCVD的额外风险,而FH+患者卒中的中性风险需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验